NCT04716257 A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients
| NCT ID | NCT04716257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West China Hospital |
| Condition | Ovarian Metastasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2021-01-14 |
| Primary Completion | 2025-09-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2021-01-14 with a primary completion date of 2025-09-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, multi-center, real-world study is conducted to investigate the impact of different treatment strategies (systemic chemotherapy combined with oophorectomy or with other local treatment or chemotherapy alone) on the prognosis of ovarian metastatic colorectal cancer patients.
Eligibility Criteria
Inclusion Criteria: 1. Histologically confirmed colorectal adenocarcinoma; 2. Histologically or radiologically diagnosed with ovarian metastasis, whether or not combined with metastases in other organs; 3. Women ≥18 years of age; 4. Eastern Cooperative Oncology Group performance status score ≤2; 5. Available imaging data if the disease is measurable according to RECIST criteria version 1.1; patients are eligible if there is no measurable lesion. 6. Complete medical records; 7. Informed consent form signed. Exclusion Criteria: 1. Not ovarian metastatic colorectal cancer confirmed by radiology or histology; 2. Drug abuse or other medical, psychological and social disorders that would interfere with cooperation with the requirements of the study; 3. Other conditions that would influence patient compliance; 4. Pregnant or breastfeeding female; male and female unwilling to take any contraceptive measures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04716257 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovarian Metastasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04716257 currently recruiting?
Yes, NCT04716257 is actively recruiting participants. Contact the research team at hxqmtg@163.com for enrollment information.
Where is the NCT04716257 trial being conducted?
This trial is being conducted at Guangzhou, China, Shenyang, China, Chengdu, China, Shanghai, China.
Who is sponsoring the NCT04716257 clinical trial?
NCT04716257 is sponsored by West China Hospital. The trial plans to enroll 400 participants.